Improved vaccines, cutting-edge mRNA medicines and accelerated drug production are at the heart of a new funding project in the U.K., where 17 companies have been selected for government grants to ...

Pharmaceutical manufacturing steps are often isolated in space and time. The synthesis, isolation and purification of the drug substance (DS) and the formulation of the drug product (DP) may be ...

Cytiva needed to expand its clean room capabilities to install additional and updated liquid pharmaceutical formulation and bottling equipment, which involved a new stand-alone structure on the Cytiva ...

The compliance process at pharmaceutical manufacturers is complicated because many still use paper-based systems to record manufacturing steps. These paper records are reviewed by FDA auditors to ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an investment of over $6 million to expand its ...

Ginkgo Bioworks (DNA) and partners awarded $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems BOSTON, April 10, ...

Zee Laboratories supplies medicines to government hospitals and institutions such as AIIMS, as well as to central and state ...

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

Shanghai IVEN Pharmatech Engineering Co. Ltd. has successfully completed a modern intravenous (IV) solution pharmaceutical plant for a US Client in the United States, marking a historic milestone as ...

Global Pharmaceutical Manufacturing Equipment Market OverviewThe global pharmaceutical manufacturing equipment market is on a growth trajectory, projected to expand at a CAGR of 6–8% over the forecast ...

The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...

This fund, with a market value worth $318.2 million, offers exposure to 30 US pharmaceutical companies. Its top five holdings include JNJ (5.12%), Abbott Laboratories ABT (5.00%), MRK (5.00%), PFE ...